Fisher Asset Management LLC Cuts Position in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC lowered its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 0.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 314,386 shares of the company's stock after selling 3,007 shares during the period. Fisher Asset Management LLC owned about 0.64% of Prestige Consumer Healthcare worth $24,550,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also made changes to their positions in the company. QRG Capital Management Inc. grew its stake in shares of Prestige Consumer Healthcare by 3.3% during the fourth quarter. QRG Capital Management Inc. now owns 5,496 shares of the company's stock worth $429,000 after purchasing an additional 176 shares in the last quarter. Proficio Capital Partners LLC acquired a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth about $1,689,000. Handelsbanken Fonder AB raised its position in shares of Prestige Consumer Healthcare by 7.6% during the 4th quarter. Handelsbanken Fonder AB now owns 15,581 shares of the company's stock worth $1,217,000 after acquiring an additional 1,100 shares in the last quarter. Ieq Capital LLC purchased a new stake in Prestige Consumer Healthcare during the fourth quarter worth approximately $239,000. Finally, New York State Common Retirement Fund boosted its holdings in Prestige Consumer Healthcare by 5.1% in the fourth quarter. New York State Common Retirement Fund now owns 16,098 shares of the company's stock valued at $1,257,000 after purchasing an additional 778 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Remove Ads

Prestige Consumer Healthcare Stock Performance

Prestige Consumer Healthcare stock traded up $2.01 during midday trading on Friday, hitting $89.10. 604,737 shares of the company's stock were exchanged, compared to its average volume of 328,521. The firm's 50 day simple moving average is $80.59 and its 200 day simple moving average is $77.63. Prestige Consumer Healthcare Inc. has a 12-month low of $62.35 and a 12-month high of $89.65. The company has a debt-to-equity ratio of 0.56, a quick ratio of 2.20 and a current ratio of 3.68. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 20.87, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a return on equity of 12.36% and a net margin of 19.13%. Equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on PBH. Oppenheimer raised their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an "outperform" rating in a report on Thursday, February 13th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a research note on Friday, January 24th. Sidoti downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "neutral" rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. Raymond James upgraded Prestige Consumer Healthcare to a "moderate buy" rating in a research report on Thursday, December 19th. Finally, DA Davidson boosted their target price on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a report on Friday, February 7th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $92.60.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.